Follow the latest coverage, related explainers and connected technology stories.
The Centers for Medicare and Medicaid Services is expanding the ACCESS program to include heart failure, chronic obstructive pulmonary disease, substance use disorders, and smoking cessation, while extending support for certain musculoskeletal conditions. The program combines outcome-linked payments with a regulatory pathway for collecting real-world data on certain digital health technologies.
The FDA selected three manufacturers to participate in the TEMPO pilot program, which aims to expand access to digital health devices intended to improve outcomes for patients with chronic diseases under the ACCESS model. The companies will collect real-world use data, while the FDA has not yet evaluated the effectiveness of the devices for the specific uses covered by the program.